Design of bioreactors for mesenchymal stem cell tissue engineering

Journal of Chemical Technology and Biotechnology

Volumn 83, Issue 4, 2008, Pages 408-420

  Godara, Pankaj ^a   McFarland, Clive D ^a   Nordon, Robert E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bioreactor; Differentiation; Mesenchymal stem cell; MSC; TE; Tissue engineering

Indexed keywords

CARTILAGE; DRUG PRODUCTS; GRAFTS; MICROFLUIDICS; TISSUE CULTURE; TISSUE ENGINEERING;

BIOPHARMACEUTICALS; MESENCHYMAL STEM CELL;

BIOREACTORS;

GROWTH FACTOR; HORMONE; HYDROXYAPATITE;

BIOREACTORS; CARTILAGE; DRUG PRODUCTS; GRAFTS; MICROFLUIDICS; TISSUE CULTURE; TISSUE ENGINEERING;

BIOREACTOR; BIOREACTOR DESIGN; BIOTECHNOLOGICAL PROCEDURES; BIOTECHNOLOGICAL PRODUCTION; BONE TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL METABOLISM; CELL PROLIFERATION; CULTURE MEDIUM; CULTURE VESSEL; DIFFUSION; FETAL CALF SERUM; GLUCOSE TRANSPORT; HUMAN; MEMBRANE PERMEABILITY; MESENCHYMAL STEM CELL; MICROCARRIER CULTURE; MICROENVIRONMENT; OXYGEN CONSUMPTION; OXYGEN TENSION; SHEAR STRESS; SHORT SURVEY; THERMODYNAMICS; TISSUE ENGINEERING;

EID: 41549164762     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.1918     Document Type: Short Survey

References (151)

1. Chao P-HG, Grayson W and Vunjak-Novakovic G, Engineering cartilage and bone using human mesenchymal stem cells. J Orthop Sci 12:398-404 (2007).
2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 58:15-25 (2007).
3. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 58:26-35 (2008).
4. Mauney JR, Volloch V and Kaplan DL, Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11:787-802 (2005).
5. Vaananen HK, Mesenchymal stem cells. Ann Med 37:469-479 (2005).
6. Lee JW, Kim YH, Park KD, Jee KS, Shin JW and Hahn SB, Importance of integrin betal-mediated cell adhesion on biodegradable polymers under serum depletion in mesenchymal stem cells and chondrocytes. Biomaterials 25:1901-1909 (2004).
7. Jeon ES, Song HY, Kim MR, Moon HJ, Bae YC, Jung JS, et al, Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. J Lipid Res 47:653-664 (2006).
8. Farré J, Roura S, Prat-Vidal C, Soler-Botija C, Llach A, Molina CE, et al, FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells. Growth Factors 25:71-76 (2007).
9. Johnstone B, Hering TM, Caplan AI, Goldberg VM and Yoo JU, In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272 (1998).
10. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S and Muneta T, In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 97:84-97 (2006).
11. Yokoyama A, Muneta T, Nimura A, Koga H, Mochizuki T, Hata Y, et al, FGF2 and dexamethasone increase the production of hyaluronan in two-dimensional culture of elastic cartilage-derived cells: in vitro analyses and in vivo cartilage formation. Cell Tissue Res 329:469-478 (2007).
12. Jaiswal N, Haynesworth SE, Caplan AI and Bruder SP, Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312 (1997).
13. Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, et al, Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745-757 (2007).
14. Murphy CL and Polak JM, Control of human articular chondrocyte differentiation by reduced oxygen tension. J Cell Physiol 199:451-459 (2004).
15. Grzelak A, Rychlik B and Bartosz G, Light-dependent generation of reactive oxygen species in cell culture media. Free Radic Biol Med 30:1418-1425 (2001).
16. Schafer FQ and Buettner GR, Redox enviromnent of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191-1212 (2001). 17 Reyes JM, Fermanian S, Yang F, Zhou SY, Herretes S, Murphy DB, et al, Metabolic changes in mesenchymal stem cells in osteogenic medium measured by autofluorescence spectroscopy. Stem Cells 24:1213-1217 (2006).
17. Chowdhury TT, Bader DL, Shelton JC and Lee DA, Temporal regulation of chondrocyte metabolism in agarose constructs subjected to dynamic compression. Arch Biochem Biophys 417:105-111 (2003).
18. Lee CR, Grodzinsky AJ and Spector M, Biosynthetic response of passaged chondrocytes in a type II collagen scaffold to mechanical compression. J Biomed Mater Res A 64:560-599 (2003).
19. Lee DA, Noguchi T, Frean SP, Lees P and Bader DL, The influence of mechanical loading on isolated chondrocytes seeded in agarose constructs. Biorheology 37:149-161 (2000).
20. Kurpinski K, Chu J, Hashi C and Li S, Anisotropic mechanosensing by mesenchymal stem cells. Proc Natl Acad Sci USA 103:16095-16100 (2006).
21. Zhao F, Chella R and Ma T, Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling. Biotechnol Bioeng 96:584-595 (2007).
22. Jiang GL, White CR, Stevens HY and Frangos JA, Temporal gradients in shear stimulate osteoblastic proliferation via ERK1/2 and retinoblastoma protein. Am J Physiol Endocrinol Metab 283:E383-389 (2002).
23. Bird BR, Steward WE and Lightfoot EN, Transport Phenomena. Wiley, New York (1960).
24. Spier RE and Griffiths B, An examination of the data and concepts germane to the oxygenation of cultured animal cells. Dev Biol Stand 55:81-92 (1983).
25. Freed LE, Vunjak-Novakovic G and Langer R, Cultivation of cell-polymer cartilage implants in bioreactors. J CellBiochem 51:257-264 (1993).
26. Galban CJ and Locke BR, Analysis of cell growth kinetics and substrate diffusion in a polymer scaffold. Biotechnol Bioeng 65:121-132 (1999).
27. Galban CJ and Locke BR, Effects of spatial variation of cells and nutrient and product concentrations coupled with product inhibition on cell growth in a polymer scaffold. Biotechnol Bioeng 64:633-643 (1999).
28. Leddy HA, Awad HA and Guilak F, Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. J Biomed Mater Res B 70:397-406 (2004).
29. Peng CA and Palsson. BO, Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng 24:373-381 (1996).
30. Dennis JE, Esterly K, Awadallah A, Parrish CR, Poynter GM and Goltry KL, Clinical-scale expansion of a mixed population of bone marrow derived stem and progenitor cells for potential use in bone tissue regeneration. Stem Cells 25:2575-2582 (2007).
31. Klein TJ and Sah RL, Modulation of depth-dependent properties in tissue-engineered cartilage with a semipermeable membrane and perfusion: a continuum model of matrix metabolism and transport. Biomech Model Mechanobiol 6:21-32 (2007).
32. Nordon RE and Schindhelm K, Design of hollow fiber modules for uniform shear elution affinity cell separation. Artif Organs 21:107-115 (1997).
33. Porter B, Zauel R, Stockman H, Guldberg R and Fyhrie D, 3-D computational modeling of media flow through scaffolds in a perfusion bioreactor. J Biomech 38:543-549 (2005).
34. Bancroft GN, Sikavitsas VI, van den Dolder J, Sheffield TL, Ambrose CG, Jansen JA, et al, Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 99:12600-12605 (2002).
35. Glowacki J, Mizuno S and Greenberger JS, Perfusion enhances functions of bone marrow stromal cells in three-dimensional culture. Cell Transplant 7:319-326 (1998).
36. Mahmoudifar N and Doran PM, Tissue engineering of human cartilage and osteochondral composites using recirculation bioreactors. Biomaterials 26:7012-7024 (2005).
37. Goldstein AS, Juarez TM, Helmke CD, Gustin MC and Mikos AG, Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 22:1279-1288 (2001).
38. Nordon RE, Method and Apparatus for Culturing Cells. Unisearch Ltd Australia, PCT/AU/01197.
39. Granet C, Laroche N, Vico L, Alexandre C and Lafage-Proust MH, Rotating-wall vessels, promising bioreactors for osteoblastic cell culture: comparison with other 3D conditions. Med Biol Eng Comput 36:513-519 (1998).
40. Yang Y, Rossi FM and Putnins EE, Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 28:3110-3120 (2007).
41. Charriere E, Lemaitre J and Zysset P, Hydroxyapatite cement scaffolds with controlled macroporosity: fabrication protocol and mechanical properties. Biomaterials 24:809-817 (2003).
42. Dellinger JG, Cesarano J 3rd and Jamison RD, Robotic deposition of model hydroxyapatite scaffolds with multiple architectures and multiscale porosity for bone tissue engineering. J Biomed Mater Res A 82:383-394 (2007).
43. Mygind T, Stiehler M, Baatrup A, Li H, Zou X, Flyvbjerg A, et al, Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials 28:1036-1047 (2007).
44. Turhani D, Watzinger E, Weissenböck M, Cvikl B, Thurnher D, Wittwer G, et al, Analysis of cell-seeded 3-dimensional bone constructs manufactured in vitro with hydroxyapatite granules obtained from red algae. J Oral Maxillofac Surg 63:673-681 (2005).
45. Ge Z, Baguenard S, Lim LY, Wee A and Khor E, Hydroxyapatite-chitin materials as potential tissue engineered bone substitutes. Biomaterials 25:1049-1058 (2004).
46. Harris CT and Cooper LF, Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res A 68:747-755 (2004).
47. Kotobuki N, Ioku K, Kawagoe D, Fujimori H, Goto S and Ohgushi H, Observation of osteogenic differentiation cascade of living mesenchymal stem cells on transparent hydroxyapatite ceramics. Biomaterials 26:779-785.
48. Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matushima A and Takakura Y, Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30:115-118 (2006).
49. De Bartolo L, Piscioneri A, Cotroneo G, Salerno S, Tasselli F, Campana C, et al, Human lymphocyte PEEK-WC hollow fiber membrane bioreactor. J Biotechnol 132:65-74 (2007).
50. Nishikawa M, Myoui A, Ohgushi H, Ikeuchi M, Tamai N and Yoshikawa H, Bone tissue engineering using novel interconnected porous hydroxyapatite ceramics combined with marrow mesenchymal cells: quantitative and three-dimensional image analysis. Cell Transplant 13:367-376 (2004).
51. Sawyer AA, Hennessy KM and Bellis SL, The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials 28:383-392 (2007).
52. Sawyer AA, Weeks DM, Kelpke SS, McCracken MS and Bellis SL, The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion. Biomaterials 26:7046-7056 (2005).
53. Yoshikawa H and Myoui A, Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8: 131-136 (2005).
54. Zhao F, Grayson WL, Ma T, Bunnell B and Lu WW, Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. Biomaterials 27:1859-1867 (2006).
55. Bensaïd W, Oudina K, Viateau V, Potier E, Bousson V, Blanchat C, et al, De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng 11:814-824 (2005).
56. Hofmann S, Hagenmüller H, Koch AM, Müller R, Vunjak-Novakovic G, Kaplan DL, et al, Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 28:1152-1162 (2007).
57. Kim HJ, Kim UJ, Leisk GG, Bayan C, Georgakoudi I and Kaplan DL, Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol Biosci 7:643-655 (2007).
58. Li C, Vepari C, Jin HJ, Kim HJ and Kaplan DL, Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27:3115-3124.
59. Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, et al, Silk implants for the healing of critical size bone defects. Bone 37:688-698 (2005).
60. Nazarov R, Jin HJ and Kaplan DL, Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 5:718-726 (2004).
61. Li X, Feng Q, Wang W and Cui F, Chemical characteristics and cytocompatibility of collagen-based scaffold reinforced by chitin fibers for bone tissue engineering. J Biomed Mater Res B 77:219-226 (2006).
62. Yang XB, Bhatnagar RS, Li S and Oreffo RO, Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 10: 1148-1159 (2004).
63. Karp JM, Shoichet MS and Davies JE, Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro. J Biomed Mater Res A 64:388-396 (2003).
64. Huang W, Carlsen B, Wulur I, Rudkin G, Ishida K, Wu B, et al, BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 299:325-334.
65. Kim WS and Kim HK, Tissue engineered vascularized bone formation using in vivo implanted osteoblast-polyglycolic acid scaffold. J Korean Med Sci 20:479-482 (2005).
66. Mahmoudifar N and Doran PM, Tissue engineering of human cartilage in bioreactors using single and composite cell-seeded scaffolds. Biotechnol Bioeng 91:338-355 (2005).
67. Wayne JS, McDowell CL, Shields KJ and Tuan RS, In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng 11:953-963 (2005).
68. Uematsu K, Hattori K, Ishimoto Y, Yamauchi J, Habata T, Takakura Y, et al, Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold. Biomaterials 26:4273-4279 (2005).
69. Dewar V, Voet P, Denamur F and Smal J, Industrial implentation of in vitro production of monoclonal antibodies. ILAR J 46:307-313 (2005).
70. Hofmann S, Knecht S, Langer R, Kaplan DL, Vunjak-Novakovic G, Merkle HP, et al, Cartilage-like tissue enginering using silk scaffolds and mesenchymal stem cells. Tissue Eng 12:2729-2738 (2006).
71. Wang Y, Kim UJ, Blasioli DJ, Kim HJ and Kaplan DL, In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 26:7082-7094 (2005).
72. Baker BM and Mauck RL, The effect of nanofiber alignment on the maturation of engineered meniscus constructs. Biomaterials 28:1967-1977 (2007).
73. Chen Z, Ding Y and Li G, Configuration of a new bioartificial liver support system and in vitro evaluation of its functions. Ann Clin Lab Sci 35:7-14 (2005).
74. Yamasaki T, Deie M, Shinomiya R, Izuta Y, Yasunaga Y, Yanada S, et al, Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow. J Biomed Mater Res A 75:23-30 (2005).
75. Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V, Zichner L, et al, Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32:112-122 (2004).
76. Schwarz RP, Goodwin TJ and Wolf DA, Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity. J Tissue Cult Methods 14:51-57 (1992).
77. Song K, Yang Z, Liu T, Zhi W, Li X, Deng L, et al, Fabrication and detection of tissue-engineered bones with bioderived scaffolds in a rotating bioreactor. Biotechnol Appl Biochem 45:65-74 (2006).
78. Qiu QQ, Ducheyne P and Ayyaswamy PS, Fabrication, characterization and evaluation of bioceramic hollow microspheres used as microcarriers for 3-D bone tissue formation in rotating bioreactors. Biomaterials 20:989-1001 (1999).
79. Duke J, Daane E, Arizpe J and Montufar-Solis D, Chondrogenesis in aggregates of embryonic limb cells grown in a rotating wall vessel. Adv Space Res 17:289-293 (1996).
80. Hu JC and Athanasiou KA, Low-density cultures of bovine chondrocytes: effects of scaffold material and culture system. Biomaterials 26:2001-2012 (2005).
81. Nettles DL, Elder SH and Gilbert JA, Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng 8:1009-1016 (2002).
82. Ohyabu Y, Kida N, Kojima H, Taguchi T, Tanaka J and Uemura T, Cartilaginous tissue formation from bone marrow cells using rotating wall vessel (RWV) bioreactor. Biotechnol Bioeng 95:1003-1008 (2006).
83. Singh V, Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 30:149-158 (1999).
84. Kadarusman J, Bhatia R, McLaughlin J and Lin WR, Growing cholesterol-dependent NSO myeloma cell line in the wave bioreactor system: overcoming cholesterol-polymer interaction by using pretreated polymer or inert fluorinated ethylene propylene. Biotechnol Prog 21:1341-1346 (2005).
85. Bancroft GN, Sikavitsas VI and Mikos AG, Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng 9:549-554 (2003).
86. Zhao F, Pathi P, Grayson W, Xing Q, Locke BR and Ma T, Effects of oxygen transport on 3-d human mesenchymal stem cell metabolic activity in perfusion and static cultures: experiments and mathematical model. Biotechnol Prog 21:1269-1280 (2005).
87. Mueller SM, Mizuno S, Gerstenfeld LC and Glowacki J, Medium perfusion enhances osteogenesis by murine osteosarcoma cells in three-dimensional collagen sponges. J Bone Miner Res 14:2118-2126 (1999).
88. Hosseinkhani H, Inatsugu Y, Hiraoka Y, Inoue S and Tabata Y, Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic acid) fiber. Tissue Eng 11:1476-1488 (2005).
89. Braccini A, Wendt D, Jaquiery C, Jakob M, Heberer M, Kenins L, et al, Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23:1066-1072 (2005).
90. Wang Y, Uemura T, Dong J, Kojima H, Tanaka J and Tateishi T, Application of perfusion culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng 9:1205-1214 (2003).
91. Wendt D, Marsano A, Jakob M, Heberer M and Martin I, Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 84:205-214.
92. Wang J, Asou Y, Sekiya I, Sotome S, Orii H and Shinomiya K, Enhancement of tissue engineered bone formation by a low pressure system improving cell seeding and medium perfusion into a porous scaffold. Biomaterials 27:2738-2746.
93. Davisson T, Sah RL and Ratcliffe A, Perfusion increases cell content and matrix synthesis in chondrocyte three-dimensional cultures. Tissue Eng 8:807-816 (2002).
94. Pazzano D, Mercier KA, Moran JM, Fong SS, DiBiasio DD, Rulfs JX, et al, Comparison of chondrogensis in static and perfused bioreactor culture. Biotechnol Prog 16:893-896 (2000).
95. Mahmoudifar N and Doran PM, Tissue engineering of human cartilage in bioreactors using single and composite cell-seeded scaffolds. Biotechnol Bioeng 91:338-355 (2005).
96. Mahmoudifar N and Doran PM, Effect of seeding and bioreactor culture conditions on the development of human tissue-engineered cartilage. Tissue Eng 12:1675-1685.
97. Dunkelman NS, Zimber MP, LeBaron RG, Pavelec R, Kwan M and Purchio AF, Cartilage production by rabbit articular chondrocytes on polyglycolic acid scaffolds in a closed bioreactor system. Biotechnol Bioeng 46:299-305 (1995).
98. Roberts CR, Rains JK, Paré PD, Walker DC, Wiggs B and bert JL, Ultrastructure and tensile properties of human tracheal cartilage. J Biomech 31:81-86 (1997).
99. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, et al, A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26:599-609 (2005).
100. Koller MR, Emerson SG and Palsson BO, Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378-384 (1993).
101. Peng CA and Palsson B, Cell growth and differentiation on feeder layers is predicted to be influenced by bioreactor geometry. Biotechnol Bioeng 50:479-492 (1996).
102. Mandalam R, Koller M and Smith A, Ex vivo hematopoietic cell expansion for bone marrow transplantation, in Ex Vivo cell Therapy, ed. by Nordon RE and Schindhelm K. Academic Press, San Diego, CA, pp. 273-291 (1999).
103. Knazek RA, Wu YW, Aebersold PM and Rosenberg SA, Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors. J Immunol Methods 127:29-37 (1990).
104. Malone CC, Schiltz PM, Mackintosh AD, Beutel LD, Heinemann FS and Dillman RO, Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer. Cancer Biother Radiopharm 16:381-390 (2001).
105. Pan D, Stroncek DF and Whitley CB, Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysacchariclosis type I using a bioreactor. J Gene Med 6:1293-1303 (2004).
106. Pan D and Whitley CB, Closed hollow-fiber bioreactor: a new approach to retroviral vector production. J Gene Med 1:433-440 (1999).
107. Gardner TA, Ko SC, Yang L, Cadwell JJ, Chung LW and Kao C, Serum-free recombinant production of adenovirus using a hollow fiber capillary system. Biotechniques 30:422-427 (2001).
108. Gramer MJ and Maas J, Optimal NSO cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber. Biotechnol Prog 19:1762-1766 (2003).
109. Kalbfuss B, Genzel Y, Wolff M, Zimmermann A, Morenweiser R and Reichl U, Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnol Bioeng 97:73-85 (2007).
110. Kuhn J, Mölle K, Brinkmann T, Götting C and Kleesiek K, High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase. J Biotechnol 103:191-196 (2003).
111. Abu-Absi SF, Seth G, Narayanan RA, Groehler K, Lai P, Anderson ML, et al, Characterization of a hollow fiber bioartificial liver device. Artif Organs 29:419-422 (2005).
112. Curcio E, De Bartolo L, Barbieri G, Rende M, Giorno L, Morelli S, et al, Diffusive and convective transport through hollow fiber membranes for liver cell culture. J Biotechnol 117:309-321 (2005).
113. Lu H-F, Lim WS, Zhang PC, Chia SM, Yu H, Mao HQ, et al, Galactosylated poly(vinylidene difluoride) hollow fiber bioreactor for hepatocyte culture. Tissue Eng 11:1667-1677 (2005).
114. Meng Q, Zhang G and Wu D, Hepatocyte culture in bioartificial livers with different membrane characteristics. Biotechnol Lett 26:1407-1412 (2004).
115. Shi Q, Mitteregger R, Falkenhagen D and Yu YT, A novel configuration of bioartificial liver support system based on circulating microcarrier culture. Artif Cells Blood Substit Immobil Biotechnol 28:273-291 (2000).
116. Potter K, Kidder LH, Levin IW, Lewis EN and Spencer RG, Imaging of collagen and proteoglycan in cartilage sections using Fourier transform infrared spectral imaging. Arthritis Rheum 44:846-855 (2001).
117. Kim M, Bi X, Horton WE, Spencer RG and Camacho NP, Fourier transform infrared imaging spectroscopic analysis of tissue engineered cartilage: histologic and biochemical correlations. J Biomed Optics 10:031105 (2005).
118. Nordon RE, Shu A, Camacho F and Milthorpe BK, Hollow fiber assay for ligand-mediated cell adhesion. Cytometry 57A:39-44 (2004).
119. Nordon RE, Milthorpe BK, Schindhelm K and Slowiaczek PR, An experimental model of affinity cell separation. Cytometry 16:25-33 (1994).
120. Heath C, Belfort G, Hammer BE, Miter SD and Pimbley JM, Magnetic resonance imaging and modeling of flow in hollow-fiber bioreactors. AIChE J 36:547-558 (1990).
121. Xia Y and Whitesides GM, Soft lithography. Annu Rev Mater Sci 28:153-184 (1998).
122. Xia Y and Whitesides GM, Soft lithography. Angew Chem Int Ed 37:550-575 (1998).
123. Kane RS, Takayama S, Ostuni E, Ingber DE and Whitesides GM, Patterning proteins and cells using soft lithography. Biomaterials 20:2363-2376 (1999).
124. Kim EJ, Xia Y and Whitesides GM, Polymer microstructures formed by moulding in capillaries. Nature 376:581-584 (1995).
125. Leclerc E, Sakai Y and Fujii T, Cell culture in 3-dimensional microfluidic structure of PDMS (polydimethylsiloxane). Biomed Microdevices 5:109-114 (2003).
126. Park TH and Shuler ML, Integration of cell culture and microfabrication technology. Biotechnol Prog 19:243-253 (2003).
127. Beer R, Hindson BJ, Wheeler EK, Hall SB, Rose KA, Kennedy IM, et al, On-chip, real-time, single-copy polymerase chain reaction in picolitre droplets. Anal Chem 79:8471-8475 (2007).
128. Gomez-Sjoberg R, Leyrat AA, Pirone DM, Chen CS and Quake SR, Versatile, fully automated, microfluidic cell culture system. Anal Chem 79:8557-8563 (2007).
129. Unger MA, Chou HP, Thorsen T, Scherer A and Quake SR, Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288:113-116 (2000).
130. Wheeler AR, Throndset WR, Whelan RJ, Leach AM, Zare RN, Liao YH, et al, Microfluidic device for single-cell analysis. Anal Chem 75:3581-3586 (2003).
131. Yin H, Pattrick N, Zhang X, Klauke N, Cordingley HC, Haswell SJ, et al, Quantitative comparison between microfluidic and microtiter plate formats for cell-based assays. Anal Chem 80:179-185 (2008).
132. Leclerc E, Sakai Y and Fujii T, Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes. Biotechnol Prog 20:750-755 (2004).
133. Leclerc E, Furukawa KS, Miyata F, Sakai Y, Ushida T and Fujii T, Fabrication of microstructures in photosensitive biodegradable polymers for tissue engineering applications. Biomaterials 25:4683-4690 (2004).
134. Leclerc E, David B, Griscom L, Lepioufle B, Fujii T, Layrolle P, et al, Study of osteoblastic cells in a microfluidic environment. Biomaterials 27:586-595 (2006).
135. Toh Y-C, Zhang C, Zhang J, Khong YM, Chang S, Samper VD, et al, A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 7:302-309 (2007).
136. Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, et al, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397 (2006).
137. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, et al, Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398 (2005).
138. Bartmann C, Rohde E, Schallmoser K, Pürstner P, Lanzer G, Linkesch W, et al, Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47:1426-1435 (2007).
139. Soloveva V, LaRocque J and McKillip E, When robots are good: fully automated thermo LAS robotic assay system with dual FLIPRTETRA and TAP select robotic cell culture system. J Assoc Lab Autom 11:145-156 (2006).
140. Korhonen M, Culture of human mesenchymal stem cells in serum-free conditions: no breakthroughs yet. Eur J Haematol 78:167,168 (2007).
141. Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M, et al, Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol 76:309-316 (2006).
142. Mizuno N, Shiba H, Ozeki Y, Mouri Y, Niitam M, Inui T, et al, Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int 30:521-524 (2006).
143. Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J and Zander AR, Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18-26 (2007).
144. Xie C, Reynolds D, Awad H, Rubery PT, Pelled G, Gazit D, et al, Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 13:435-445 (2007).
145. Martin I, Miot S, Barbero A, Jakob M and Wendt D, Osteochondral tissue engineering. J Biomech 40:750-765 (2007).
146. von Heimburg D, Hemmrich K, Zachariah S, Staiger H and Pallua N, Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells. Resp Physiol Neurobiol 146:107-116 (2005).
147. Malda J, van den Brink P, Meeuwse P, Grojec M, Martens DE, Tramper J, et al, Effect of oxygen tension on adult articular chondrocytes in microcarrier bioreactor culture. Tissue Eng 10:987-994 (2004).
148. Lewis MC, Macarthur BD, Malda J, Pettet G and Please CP, Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension. Biotechnol Bioeng 91:607-615 (2005).
149. Markusen JF, Mason C, Hull DA, Town MA, Tabor AB, Clements M, et al, Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng 12:821-830 (2006).
150. Tomita M, Sato EF, Nishikawa M, Yamano Y and Inoue M Nitric oxide regulates mitochondrial respiration and functions of articular chondrocytes. Arthritis Rheum 44:96-104 (2001).
151. Windhaber RA, Wilkins RJ and Meredith D, Functional characterisation of glucose transport in bovine articular chondrocytes. Pflugers Arch Eur J Physiol 446:572-577.